- In January 2025, Haemonetics Corporation, a global leader in blood and platelet management, announced the launch of its new Platelet Function Analyzer 5000. The device provides enhanced accuracy and efficiency for platelet aggregation testing, enabling better monitoring of platelet function during therapeutic interventions. This innovation will be crucial in optimizing treatment regimens for patients with thrombotic disorders and improving clinical outcomes
- In October 2024, Bio/Data Corporation presented its latest PFA-100 Platelet Function Analyzer at the American Society of Hematology conference. The device is designed to provide real-time, high-throughput analysis of platelet function, enhancing the diagnostic capabilities of healthcare providers in managing bleeding disorders and cardiovascular diseases. This system integrates advanced technologies for more reliable testing results, enabling better patient-specific treatment strategies
- In September 2024, Chrono-Log Corporation introduced its upgraded Model 700 Platelet Aggregation System. The new system features enhanced precision in platelet aggregation testing, coupled with faster data processing, allowing healthcare providers to make quicker, more informed decisions in managing patients with platelet dysfunction. The upgrade also includes new software for more comprehensive data analysis and better clinical decision-making
- In September 2024, Werfen unveiled the Multiplate Analyzer, a cutting-edge device used for measuring platelet function. The device is known for its user-friendly interface and high sensitivity in detecting platelet dysfunction, which is vital for the diagnosis and management of thrombotic conditions. The company is set to further expand the device's capabilities with additional software enhancements to aid in personalized patient care
